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With the increase in antibiotic resistance among infectious diseases, the need for new
strategies for identifying compounds with inhibitory effects is dire. Traditional methods
of genome sequencing and systematic characterization of potential antimicrobial
gene clusters, although effective, are unfortunately not yielding results at a speed
consistent with the rise in antimicrobial resistance. One approach could be to use a
more targeted approach to antimicrobial compound discovery. Insect vectors often
mediate the transmissions of parasitic infections for example, leishmaniasis, malaria,
and trypanosomiasis. Within the insect, among the pathogens, are commensal and/or
obligate symbiotic bacteria, which often undergo a population shift upon colonization
of the insect host. The remaining bacteria may be either resistant to the effects
of the respective parasites, or possibly essential for a successful colonization and
continued spread of the parasite due to an obligate symbiosis between bacteria and
insect host. Interestingly, these shifts are often toward groups of bacteria known to
harbor many polyketide synthase and non-ribosomal peptide synthetase gene clusters
involved in bioactive molecule production. This perspective explores the possibility to
exploit the natural interactions between parasite, symbiont, and insect host for a more
targeted approach toward natural product discovery, in an environment where potential
compound producers are naturally interfacing with human pathogens.
Keywords: natural products, symbiosis, microbiome, secondary metabolites, non-ribosomal peptide synthetase,
polyketide synthase
INTRODUCTION
Antibiotic resistance is estimated to cause approximately 10 million deaths per year by 2050
(O’Neill, 2016). Despite this, natural compounds with antibiotic properties are widespread in the
environment, produced by organisms found in environments ranging from deep-sea water in the
Arctic (Yuan et al., 2014) to plants in tropical rainforests (Qin et al., 2009). However, the major
impediment to new antimicrobials in clinical use, is that the discovery of new compounds with
potential clinical applications is simply too slow to keep up with the rise of resistance. Natural
product research has now developed into an enormous field and is significantly simplified with the
advent of easily accessible, low-cost, high-throughput sequencing technologies. This simplification
would suggest that we should be finding novel antibiotics much faster than previously, which
unfortunately is not currently the case.
Insects, like other eukaryotes, have a lifestyle and diet that is often complemented (and
influenced) through interactions with microorganisms (Yun et al., 2014). Whether supplying
enzymatic capabilities, nutrient exchange, defense against competing organisms, or host signaling,
mutualistic symbioses are widespread in nature. Underlying these interactions are complex
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layers of regulation in both the host and their normal flora.
However, the gut-microbial population is in a constant state
of flux and the composition can be heavily influenced by diet
(Muegge et al., 2011).
Insects are the responsible vectors for several parasitic diseases
including African sleeping sickness (African trypanosomiasis),
Chagas disease (American trypanosomiasis), malaria, and
leishmaniasis. The responsible insects are very different for each
disease, maintain different feeding patterns and therefore have
their own unique repertoire of microbial flora. However, what
they all have in common is a blood feeding stage in their life
cycle. Following a blood meal, the microbial contents of the gut
changes (Wang et al., 2011; Diaz-Albiter et al., 2012; Buarque
et al., 2016) and in some cases, this microbial shift may affect the
outcome of successful colonization by parasites (Tchioffo et al.,
2013; Geiger et al., 2015). The mechanism(s) of support for the
host are not always fully elucidated. Candidates for involvement
in these processes are secondary metabolites (SMs), which are
generally considered to be non-essential to survival. However,
these natural products, often produced by either non-ribosomal
peptide synthetases (NRPSs) or polyketide synthases (PKSs),
have a well described role in supporting symbioses between
vertebrates and either bacteria or fungi (Beemelmanns et al.,
2016). NRPSs and PKSs are large protein complexes, which
produce small compounds that often have medically relevant
biological activities. Here, the idea that some of these SM may
contain activity against invading parasites within the gut of
different insect species is explored.
MICROBIOME OF Lutzomyia longipalpis
Lutzomyia longipalpis is a major vector responsible for
transmission of visceral Leishmaniasis. Early on, studies
in phlebotomines related to L. longipalpis, highlighted an
interesting observation regarding the microflora of Phlebotomus
females – where large amounts of bacteria were present in the
gut, Leishmania transmission was impacted in a negative way
(Schlein et al., 1985). What followed after many years, was a
study in L. longipalpis, where bacterial symbionts were found to
defend directly against colonization of Leishmania. The authors
noted that where bacteria were present prior to exposure of the
sandfly to Leishmania, Leishmania infection was less likely to
establish a foothold within the gut of the sandfly (Sant’Anna
et al., 2014). This observation is not surprising, nor is it an
isolated incident with increased microbial diversity in a locust
gut found to also be protective against invasion of pathogens
(Dillon et al., 2005). Conversely, and perhaps more interestingly,
when the roles were switched and Leishmania first colonized
the sand fly gut, the parasite provided protection against
bacterial pathogens (Sant’Anna et al., 2014). The finding that
microbial flora can be protective leads to the obvious question
of how? A study taking inventory of the species present by
mapping shotgun transcriptome data to the nucleotide databases
provided some insights (McCarthy et al., 2011). Although not
a targeted approach specifically for symbiont detection, the
study identified several bacteria and fungi that contain SM gene
clusters. Presumably, the bacteria identified are those present in
higher numbers due to the global approach (insect transcripts
accounted for the majority of reads) the researchers took.
However, examining available genomes of those bacteria and
fungi named, account for 70 SM clusters, collectively (Table 1)
with potentially interesting bioactivities. With high bacterial
loads being somewhat protective against parasitic colonization
followed by the fact that the bacterial load contains a reasonably
large number of SM producing gene clusters, it seems reasonable
to expect that at least some of these bacteria may produce
metabolites that somehow, specifically inhibit the parasite.
MICROBIOME OF Anopheles
Studies frequently focus on the microbial diversity of insect
species, with their specific roles not definitively determined.
One exhaustive study examined the microbiome of Anopheles
and nicely analyzed much of the data available, identifying
a total of 109 unique genera with many different reported
effects on the fitness of Plasmodium spp. but no overall
role for the symbionts (Villegas et al., 2014). Although we
should be best placed to determining the role of symbionts in
mosquitos given the extensive number of studies performed,
the complexity of the microbiome in different species has
complicated this. Despite different mosquito species occupying
very different niches and developing under different conditions,
Proteobacteria appear to be the most frequently identified
phylum (Minard et al., 2013). Within the Proteobacteria, there
do exist examples of anti-parasite producing flora strengthening
the idea that these environments could be a rich source
of new anti-parasitic compounds. One example is Serratia
marcescens that was isolated from Anopheles albimanus and
found to be capable of eviscerating the oocyst development
of Plasmodium vivax (Gonzalez-Ceron et al., 2003) as well
as showing some anti-trypanosomal activity in the gut of
Rhodnius prolixus, a common Chagas disease insect vector
(Azambuja et al., 2004). S. marcescens is commonly found in
the environment and is a known SM producer. One possibility
explaining the production of anti-parasitic compounds under
certain environmental conditions is niche adaptation in some
strains, thereby allowing the bacteria a selective advantage in
colonizing the gut of these insects.
MICROBIOME IN CHAGAS DISEASE
VECTORS
Trypanosoma cruzi is the causative agent of Chagas disease and
is spread by various species of triatomine. Triatoma infestans and
R. prolixus are two common triatomine species that spread the
disease in South and Central America, respectively. Survival of
these insect vectors of Chagas disease are known to be dependent
on their bacterial symbionts, at least for the production of
B-complex vitamins that are typically lacking from the blood
diet maintained by the insects (Baines, 1956; Harington, 1960).
In R. prolixus, the bacteria determined to be responsible for
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TABLE 1 | Break down of secondary metabolite (SM) clusters identified from bacteria and fungi highlighted in metagenomic studies focusing on insect
vectors of Leishmaniasis and Chagas disease.
Insect species Insect flora NRPS PKS Bacteriocin Other Total Reference
Lutzomyia longipalpis Anoxybacillus flavithermus 0 1 2 3 6 NC_011567.1
Ralstonia pickettii 0 1 0 3 4 NC_010682.1
Propionibacterium acnes 1 0 1 1 3 NC_006085.1
Geobacillus kaustophilus 0 1 2 1 4 NC_006510.1
Streptomyces coelicolor 3 8 2 14 27 NC_003888.3
Leifsonia xyli 0 0 0 2 2 NC_022438.1
Acinetobacter baumannii 2 0 0 3 5 NZ_CP009257.1
Cunninghamella bertholletiae 1 0 0 5 6 JNEG00000000.1
Mortierella verticillata 4 0 0 9 13 AEVJ00000000.1
Total 11 11 7 41 70 McCarthy et al., 2011
Triatoma spp. Corynebacterium stationis 0 1 0 2 3 CP014279.1
Corynebacterium casei 0 1 0 3 4 NZ_CP004350.1
Corynebacterium glutamicum 0 1 0 3 4 NC_022040.1
Gordonia sp. KTR9 7 1 1 6 15 NC_018581.1
Dietzia maris 1 1 0 5 7 NZ_LVFF00000000.1
Serratia marcescens WW4 4 0 0 0 4 NC_020211.1
Total 12 5 1 19 37 Gumiel et al., 2015
Representative species mentioned in analysis of the visceral Leishmaniasis vector, Lutzomyia longipalpis (McCarthy et al., 2011) and two vectors for Chagas disease,
Triatoma brasiliensis and Triatoma pseudomaculata (Gumiel et al., 2015) were used in antiSMASH v3.0 (Weber et al., 2015) to identify secondary metabolite clusters.
Where a specific strain was not named, a representative genome from the species was used as an example. All references refer to GenBank accession numbers. The
‘other’ column includes all those clusters not falling into one of NRPS, PKS or bacteriocin.
this is the actinomycete, Rhodococcus rhodnii (Baines, 1956).
Interestingly, these bacteria are not obligate symbionts of the
Chagas disease vectors, T. infestans (Nocardia sp.), Panstrongylus
megistus (Gordonia sp.) or Triatoma sordida (Rhodococcus equi)
(Eichler and Schaub, 2002). Members of the genera associated
with these other symbionts are, however, known prolific SM
producers. The question as to whether or not this is simply
a coincidence is a valid one. One cannot, however, ignore the
fact that the effect on these symbionts upon ingestion of a
given parasite results in an initial decrease in symbiont numbers,
followed by recovery and subsequently significantly higher
numbers of symbiotic bacteria, suggesting that these symbionts
are somewhat resilient to parasitic attack (Eichler and Schaub,
2002). The decrease in microbe numbers has been attributed
to the triggering of antimicrobial peptides by the incoming
parasite. However, not all bacteria are affected and prior to the
recovery reported by Eichler and Schaub (2002), pyrosequencing
of the R. prolixus gut compartments demonstrates a decrease
in the Enterococcaceae and Mycobacteriaceae populations but
an increase in Burkholderiaceae members and no change in
the Nocardiaceae or Enterobacteriaceae in Trypanosoma rangeli
infected insects, resulting in a net increase of SM producing
bacterial families (Vieira et al., 2015). The role of SM in
this process is as yet unknown, however, there are many
SM playing roles in defense against various competitors in
similar interactions in the environment (Beemelmanns et al.,
2016).
The observation of SM-producing insect microbiota is
continued beyond just the symbionts of the triatomines.
A metagenomic study exploring other gut microbiota of
Triatoma spp. collected from peridomestic habitats highlighted
an over-abundance of actinomycetes and Proteobacteria (Gumiel
et al., 2015). The potential SM clusters from the bacteria identified
(whether transient or commensal) in this study, totaled 37
(Table 1). In fact, upon the uptake of T. cruzi by insects, the
gut flora has shown to be, in some instances, naturally protective
against T. cruzi. This was shown to be through the production
and secretion of prodigiosin, a SM produced by S. marcescens
(Azambuja et al., 2004). In addition to the SM producing bacteria,
an earlier study analyzing the mycobiome of five separate
Triatoma spp. identified a total of 393 individual fungal strains
predominantly from the genera Penicillium, Aspergillus, and
Acremonium (Moraes et al., 2001), which are all known to be
prolific producers of SM, further supporting the antimicrobial
potential of these insect flora.
FUTURE PERSPECTIVES AND
CONCLUDING REMARKS
It is well known that gut microbiota play important roles in
protecting against disease (Azambuja et al., 2004; Yilmaz et al.,
2014). This is not limited, however, to just insect guts, but
is indeed also true in the human gut (Shreiner et al., 2015).
The maintenance of SM gene clusters, coupled with the proven
ability of microbial flora to protect against diseased states raises
the question as to the specific role of SM in these symbioses.
Why are organisms with such a number of SM gene clusters
consistently maintained while others are lost? Perhaps this is
entirely a coincidence, however, coupled with the important role
of SM in other symbioses (Beemelmanns et al., 2016), this point
is worth further investigation.
Frontiers in Microbiology | www.frontiersin.org 3 December 2016 | Volume 7 | Article 2085
fmicb-07-02085 December 20, 2016 Time: 14:59 # 4
Tobias Antimicrobials from Insect Symbionts
Products of NRPSs and PKSs have been touted as one of
the major hopes for new antibiotic discovery in the current
generation. Indeed many current antibiotics are products
(or derivatives) of these enzymatic complexes. Despite this,
resistance to multiple current antibiotics used for specific disease
is continually increasing, for example tuberculosis (Migliori
et al., 2007) and gonorrhea (Unemo and Nicholas, 2012). Next
generation sequencing has generated a huge influx of data and
created a major bottleneck in product discovery from these NRPS
or PKS clusters, particularly those that have potential for use
in human medicine. One interesting, albeit underrepresented
approach in the literature, is a functionally targeted approach
to natural product discovery where investigations of microbial
sources are performed in the context of natural interactions
between symbiont and human pathogen. With a population
shift upon infection of parasites in insects, one might ask
the question, why do some bacteria survive while others
appear to be completely removed from the environment? It
is known that parasites produce antimicrobial compounds
that are probably responsible for this shift, either directly or
indirectly (Castro et al., 2012; Vieira et al., 2015). However,
there is also the possibility that in fact, there is a complex
signaling pathway in place that leads to the removal of specific
non-essential flora. It makes sense that these compounds
produced by the parasite are somehow targeting bacteria that
would otherwise impede its entrance and replication within
the insect. Yet how are these bacteria being depleted? Is it
a direct response from the parasite? Or is it an indirect
response caused by the presence of the insect on other
commensal bacteria causing them to produce compounds such
as bacteriocins?
Secondary metabolites from some bacteria are already known
to influence insect immune systems (Downer et al., 1997;
Crawford et al., 2012; Dudnik et al., 2013). This theme of SM
maintenance may thus prove to simply be essential for optimizing
conditions for parasite colonization. Regardless, understanding
the complex interactions that occur in microbial-invertebrate
interactions could be one important step to understanding both
how and why these populations are shifting. The mechanisms
which make these particular species apparently immune from
removal following parasite entry is one which should be explored
as it may additionally provide leads as to how to prevent the
human stage of parasite replication, or at least shift the balance in
favor of clearance from the host. This understanding could also
be exploited by equipping commensal organisms with the ability
to stimulate insect immune responses in a non-beneficial way
toward the incoming parasite to prevent parasite colonization,
or offensive tools that directly target the parasites as they are
acquired in a paratransgenic approach. Indeed, some studies have
already identified anti-parasitic compounds, as discussed above,
yet the full potential of the microbiome and particularly the
mycobiome has yet to be exploited.
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